GlassScriptPhysician profile
Courtney N Bender
NPI 1538455027
$3,343.43
in general payments reported to CMS, 2019-2025
42 companies · $618 in 2025
The $618 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $188 · 2021: $554 · 2022: $359 · 2023: $650 · 2024: $721 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $916.80 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $271.58 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $169.53 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $156.04 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $149.91 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Takeda Pharmaceuticals U.S.A., INC. | $133.62 | 2019-2024 | Elaprase, Trintellix |
| Amgen INC. | $121.34 | 2019-2023 | Evenity, Prolia, Repatha |
| Corium, LLC | $108.22 | 2021-2025 | Azstarys |
| Axsome Therapeutics, INC. | $95.55 | 2022-2025 | Auvelity |
| Sanofi Pasteur INC. | $83.81 | 2022-2023 | |
| Lilly USA, LLC | $78.26 | 2019-2024 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $71.60 | 2020-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.51 | 2023-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $68.73 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.81 | 2021-2024 | Trulance, Xifaxan |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.